42 research outputs found

    A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

    Get PDF
    Meeting abstrac

    PAR2-induced inflammatory responses in human kidney tubular epithelial cells

    No full text
    Vesey DA, Suen JY, Seow V, Lohman RJ, Liu L, Gobe GC, Johnson DW, Fairlie DP. PAR2-induced inflammatory responses in human kidney tubular epithelial cells. Am J Physiol Renal Physiol 304: F737-F750, 2013. First published January 2, 2013; doi:10.1152/ajprenal.00540.2012.-Protease-activated receptor-2 (PAR2) is a G protein-coupled receptor abundantly expressed in the kidney. The aim of this study was to profile inflammatory gene and protein expression induced by PAR2 activation in human kidney tubular epithelial cells (HTEC). A novel PAR2 antagonist, GB88, was used to confirm agonist specificity. Intracellular Ca2+ (iCa(2+)) mobilization, confocal microscopy, gene expression profiling, qRTPCR, and protein expression were used to characterize PAR2 activation. PAR2 induced a pronounced increase in iCa(2+) concentration that was blocked by the PAR2 antagonist. Treatment with SLIGKV-NH2 at the apical or basolateral cell surface for 5 h induced expression of a range of inflammatory genes by greater than fourfold, including IL-1 beta, TRAF1, IL-6, and MMP-1, as assessed by cDNA microarray and qRTPCR analysis. Using antibody arrays, GM-CSF, ICAM-1, TNF-alpha, MMP-1, and MMP-10 were among the induced proteins secreted. Cytokine-specific ELISAs identified three-to sixfold increases in GM-CSF, IL-6, IL-8, and TNF-alpha, which were blocked by GB88 and protein kinase C inhibitors. Treatment of cells at the basolateral surface induced more potent inflammatory responses, with release of MCP-1 and fibronectin to the apical and basolateral compartments; apical treatment only increased secretion of these factors to the apical compartment. PAR2 activation at the basolateral surface dramatically reduced transepithelial electrical resistance (TEER) whereas apical treatment had no effect. There was very little leakage

    Effects of carbohydrates-BCAAs-caffeine ingestion on performance and neuromuscular function during a 2-h treadmill run: a randomized, double-blind, cross-over placebo-controlled study

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Carbohydrates (CHOs), branched-chain amino acids (BCAAs) and caffeine are known to improve running performance. However, no information is available on the effects of a combination of these ingredients on performance and neuromuscular function during running.</p> <p>Methods</p> <p>The present study was designed as a randomized double-blind cross-over placebo-controlled trial. Thirteen trained adult males completed two protocols, each including two conditions: placebo (PLA) and Sports Drink (SPD: CHOs 68.6 g.L<sup>-1</sup>, BCAAs 4 g.L<sup>-1</sup>, caffeine 75 mg.L<sup>-1</sup>). Protocol 1 consisted of an all-out 2 h treadmill run. Total distance run and glycemia were measured. In protocol 2, subjects exercised for 2 h at 95% of their lowest average speeds recorded during protocol 1 (whatever the condition). Glycemia, blood lactate concentration and neuromuscular function were determined immediately before and after exercise. Oxygen consumption (<inline-formula><m:math xmlns:m="http://www.w3.org/1998/Math/MathML" name="1550-2783-8-22-i1"><m:mover accent="true"><m:mrow><m:mstyle class="text"><m:mtext class="textsf" mathvariant="sans-serif">V</m:mtext></m:mstyle></m:mrow><m:mo class="MathClass-op">˙</m:mo></m:mover><m:msub><m:mrow><m:mstyle class="text"><m:mtext class="textsf" mathvariant="sans-serif">O</m:mtext></m:mstyle></m:mrow><m:mrow><m:mn>2</m:mn></m:mrow></m:msub></m:math></inline-formula>), heart rate (HR) and rate of perceived exertion (RPE) were recorded during the exercise. Total fluids ingested were 2 L whatever the protocols and conditions.</p> <p>Results</p> <p>Compared to PLA, ingestion of SPD increased running performance (p = 0.01), maintained glycemia and attenuated central fatigue (p = 0.04), an index of peripheral fatigue (p = 0.04) and RPE (p = 0.006). Maximal voluntary contraction, <inline-formula><m:math xmlns:m="http://www.w3.org/1998/Math/MathML" name="1550-2783-8-22-i1"><m:mover accent="true"><m:mrow><m:mstyle class="text"><m:mtext class="textsf" mathvariant="sans-serif">V</m:mtext></m:mstyle></m:mrow><m:mo class="MathClass-op">˙</m:mo></m:mover><m:msub><m:mrow><m:mstyle class="text"><m:mtext class="textsf" mathvariant="sans-serif">O</m:mtext></m:mstyle></m:mrow><m:mrow><m:mn>2</m:mn></m:mrow></m:msub></m:math></inline-formula>, and HR did not differ between the two conditions.</p> <p>Conclusions</p> <p>This study showed that ingestion of a combination of CHOs, BCAAs and caffeine increased performance by about 2% during a 2-h treadmill run. The results of neuromuscular function were contrasted: no clear cut effects of SPD were observed.</p> <p>Trial registration</p> <p>ClinicalTrials.gov, <url>http://www.clinicaltrials.gov</url>, <a href="http://www.clinicaltrials.gov/ct2/show/NCT00799630">NCT00799630</a></p
    corecore